Researchmoz added Most up-to-date research on "Opioid Use Disorder: Epidemiology Forecast to 2027" to its huge collection of research reports.
Opioid use disorder (OUD) is defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) as a problematic pattern of opioid use leading to clinically significant impairment or distress.
Get a Sample PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=1978231
Symptoms of OUD include strong desire for opioids, inability to control or reduce use, continued use despite interference with major obligations or social functioning, use of larger amounts over time, development of tolerance, spending a great deal of time to obtain and use opioids, and withdrawal symptoms that occur after stopping or reducing use, such as negative mood, nausea or vomiting, muscle aches, diarrhea, fever, and insomnia.
This epidemiology forecast for OUD is supported by historical data obtained from peer-reviewed articles and population-based studies. These sources used questionnaires and various diagnostic measures to assess OUD symptoms across the 8MM. The forecast methodology was kept consistent across the 8MM to allow for a meaningful comparison of the prevalent cases of OUD across these markets.
In the 8MM, the one-year total prevalent cases of POUD are expected to increase from 2,591,532 cases in 2017 to 2,780,928 cases in 2027, at an Annual Growth Rate (AGR) of 0.73%. In 2027, the US will have the highest number of one-year total prevalent cases of POUD in the 8MM with 2,477,169 one-year total prevalent cases, whereas Belgium will have the fewest number of one-year total prevalent cases with 4,386 cases. In the 8MM, the one-year total prevalent cases of NMPOUD are expected to increase from 3,155,863 cases in 2017 to 3,292,724 cases in 2027, at an AGR of 0.43%.
Scope
- The Opioid Use Disorder (OUD) Epidemiology Report provides an overview of the risk factors and global trends of OUD in the eight major markets (8MM: US, Canada, Australia, Germany, Austria, Denmark, Switzerland, and Belgium).
- This report also provides a 10-year epidemiological forecast for the one-year total prevalent cases (including both diagnosed and undiagnosed) of prescription opioid use disorder (POUD) and non-medical prescription opioid use disorder (NMPOUD) segmented by sex, age, and severity (mild, moderate, and severe) in the 8MM.
- The OUD epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
Get complete TOC with Tables and Figures at: https://www.researchmoz.us/opioid-use-disorder-epidemiology-forecast-to-2027-report.html/toc
Reasons to buy
The OUD Epidemiology report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global OUD market.
- Quantify patient populations in the global OUD market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for OUD therapeutics in each of the markets covered.
- Understand magnitude of OUD severity segments.
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us ;
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow us on Blogger at : https://marketreportandanalysis.blogspot.com
Opioid use disorder (OUD) is defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) as a problematic pattern of opioid use leading to clinically significant impairment or distress.
Get a Sample PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=1978231
Symptoms of OUD include strong desire for opioids, inability to control or reduce use, continued use despite interference with major obligations or social functioning, use of larger amounts over time, development of tolerance, spending a great deal of time to obtain and use opioids, and withdrawal symptoms that occur after stopping or reducing use, such as negative mood, nausea or vomiting, muscle aches, diarrhea, fever, and insomnia.
This epidemiology forecast for OUD is supported by historical data obtained from peer-reviewed articles and population-based studies. These sources used questionnaires and various diagnostic measures to assess OUD symptoms across the 8MM. The forecast methodology was kept consistent across the 8MM to allow for a meaningful comparison of the prevalent cases of OUD across these markets.
In the 8MM, the one-year total prevalent cases of POUD are expected to increase from 2,591,532 cases in 2017 to 2,780,928 cases in 2027, at an Annual Growth Rate (AGR) of 0.73%. In 2027, the US will have the highest number of one-year total prevalent cases of POUD in the 8MM with 2,477,169 one-year total prevalent cases, whereas Belgium will have the fewest number of one-year total prevalent cases with 4,386 cases. In the 8MM, the one-year total prevalent cases of NMPOUD are expected to increase from 3,155,863 cases in 2017 to 3,292,724 cases in 2027, at an AGR of 0.43%.
Scope
- The Opioid Use Disorder (OUD) Epidemiology Report provides an overview of the risk factors and global trends of OUD in the eight major markets (8MM: US, Canada, Australia, Germany, Austria, Denmark, Switzerland, and Belgium).
- This report also provides a 10-year epidemiological forecast for the one-year total prevalent cases (including both diagnosed and undiagnosed) of prescription opioid use disorder (POUD) and non-medical prescription opioid use disorder (NMPOUD) segmented by sex, age, and severity (mild, moderate, and severe) in the 8MM.
- The OUD epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
Get complete TOC with Tables and Figures at: https://www.researchmoz.us/opioid-use-disorder-epidemiology-forecast-to-2027-report.html/toc
Reasons to buy
The OUD Epidemiology report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global OUD market.
- Quantify patient populations in the global OUD market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for OUD therapeutics in each of the markets covered.
- Understand magnitude of OUD severity segments.
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us ;
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow us on Blogger at : https://marketreportandanalysis.blogspot.com
No comments:
Post a Comment